156 related articles for article (PubMed ID: 1500393)
1. Intraperitoneal therapy in the management of patients with ovarian cancer.
McClay EF; Howell SB
Hematol Oncol Clin North Am; 1992 Aug; 6(4):915-26. PubMed ID: 1500393
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal chemotherapy for ovarian carcinoma.
Markman M
Biomed Pharmacother; 1987; 41(8):420-4. PubMed ID: 3330457
[TBL] [Abstract][Full Text] [Related]
3. Nursing perspectives on intraperitoneal chemotherapy.
Hoff ST
J Intraven Nurs; 1991; 14(5):309-14. PubMed ID: 1748914
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal antineoplastic agents in the management of ovarian cancer.
Tropé C; Kaern J; Vergote I
Eur J Surg Suppl; 1991 May; (561):83-6. PubMed ID: 1720054
[No Abstract] [Full Text] [Related]
5. The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients.
Naumann RW; Alvarez RD; Partridge EE; Kilgore LC; Austin JM
Gynecol Oncol; 1993 Sep; 50(3):291-3. PubMed ID: 8406189
[TBL] [Abstract][Full Text] [Related]
6. [Intraperitoneal treatment of tumors of the ovary].
Wendling C; Dufour P; Oberling F
J Gynecol Obstet Biol Reprod (Paris); 1991; 20(2):241-7. PubMed ID: 2071869
[TBL] [Abstract][Full Text] [Related]
7. [Results of intraperitoneal chemotherapy of ovarian cancer].
de Gramont A; Marpeau L; Demuynck B; Louvet C; Varette C; Gonzalez-Canali G; Pigné A; Herbulot P; Lagadec B; Cady J
J Gynecol Obstet Biol Reprod (Paris); 1991; 20(3):387-92. PubMed ID: 1869784
[TBL] [Abstract][Full Text] [Related]
8. Complications associated with intraperitoneal chemotherapy catheters.
Makhija S; Leitao M; Sabbatini P; Bellin N; Almadrones L; Leon L; Spriggs DR; Barakat R
Gynecol Oncol; 2001 Apr; 81(1):77-81. PubMed ID: 11277654
[TBL] [Abstract][Full Text] [Related]
9. [The use and nursing of intraperitoneal chemotherapy for ovarian cancer].
Gao SY; Han JH; Li HY
Zhonghua Hu Li Za Zhi; 1996 Apr; 31(4):211-2. PubMed ID: 8826214
[No Abstract] [Full Text] [Related]
10. The clinical setting and pharmacology of intraperitoneal chemotherapy: an overview.
Myers CE
Semin Oncol; 1985 Sep; 12(3 Suppl 4):12-6. PubMed ID: 4048971
[TBL] [Abstract][Full Text] [Related]
11. [Complications following implantatation of a Tenckhoff catheter for the intraperitoneal administration of chemotherapeutic agents].
de Graaf PW; ten Bokkel Huinink WW; Aartsen EJ; Mellema MM; Dubbelman R; Hart AA
Ned Tijdschr Geneeskd; 1987 Feb; 131(8):323-6. PubMed ID: 3561578
[No Abstract] [Full Text] [Related]
12. [Functioning of implantable catheters of intraperitoneal chemotherapy].
de Gramont A; Marpeau L; Demuynck B; Gonzalez-Canali G; Pigné A; Herbulot P; Lagadec B; Cady J; Couturier JY; Delfau S
J Gynecol Obstet Biol Reprod (Paris); 1991; 20(3):381-5. PubMed ID: 1869783
[TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma.
McCreath WA; Eisenhauer EL; Abu-Rustum NR; Venkatraman ES; Caceres A; Bier R; Huh J; Cho J; Barakat RR; Chi DS
Gynecol Oncol; 2006 Jul; 102(1):8-14. PubMed ID: 16427689
[TBL] [Abstract][Full Text] [Related]
14. Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: from laboratory bench to bedside.
de Bree E; Theodoropoulos PA; Rosing H; Michalakis J; Romanos J; Beijnen JH; Tsiftsis DD
Cancer Treat Rev; 2006 Oct; 32(6):471-82. PubMed ID: 16942841
[TBL] [Abstract][Full Text] [Related]
15. Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancer.
Almadrones L
Clin J Oncol Nurs; 2007 Apr; 11(2):211-6. PubMed ID: 17573270
[TBL] [Abstract][Full Text] [Related]
16. Implementation of intraperitoneal chemotherapy for the treatment of ovarian cancer.
Hydzik C
Clin J Oncol Nurs; 2007 Apr; 11(2):221-5. PubMed ID: 17573271
[TBL] [Abstract][Full Text] [Related]
17. Role of intraperitoneal chemotherapy in the front-line setting.
Markman M
J Clin Oncol; 2003 May; 21(10 Suppl):145s-148s. PubMed ID: 12743130
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal chemotherapy in the management of ovarian cancer.
Ozols R
Semin Oncol; 1985 Sep; 12(3 Suppl 4):75-80. PubMed ID: 4048980
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group study.
Feun LG; Blessing JA; Major FJ; DiSaia PJ; Alvarez RD; Berek JS
Gynecol Oncol; 1998 Dec; 71(3):410-5. PubMed ID: 9887240
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal interferon-alpha in residual ovarian carcinoma: a phase II gynecologic oncology group study.
Berek JS; Markman M; Stonebraker B; Lentz SS; Adelson MD; DeGeest K; Moore D
Gynecol Oncol; 1999 Oct; 75(1):10-4. PubMed ID: 10502418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
